Normally, skin cells take about a month to form and rise to the surface. In people with psoriasis, this process happens in ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

How Does Psoriasis Increase Your Risk of Developing Other Conditions? Psoriasis is much more than a skin condition. Though it ...

How to tell if you have psoriasis or ringworm as these two skin conditions look similar but need completely different ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Autoimmune disorders are sometimes viewed as separate conditions, joint pain in rheumatoid arthritis, skin lesions in ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...

Low testosterone and limited sleep emerged as key, independent contributors to psoriasis risk, revealing modifiable targets ...